KMLabs receives new funding, appoints Kevin Fahey as CEO

(Image: KMLabs)Ultrafast-laser maker KMLabs (Boulder, CO) has appointed Kevin P. Fahey, Ph.D., as its new CEO. Fahey will help KMLabs in its push to develop new products aimed at biological imaging, chemical spectroscopy, semiconductor and materials applications, and other uses. This next stage for KMLabs is enabled by a growth-phase equity round with participation from existing investors, including Intel Capital and the Colorado Impact Fund. The funding will support the release of robust industrialized versions of KMLabs’ latest lasers to the scientific and industrial community. KMLabs produces ultrafast Ti:sapphire and ultrafast fiber-laser technologies, as well as the world's only fully-engineered coherent EUV/VUV high harmonic generation sources. The company's products fall within laptop-to-tabletop-sized form factors. "We are very excited to begin building the collaborations and the community that will enable emergent technologies like 3- and 4-photon microscopy, 2D-IR, and ultrafast photoemission spectroscopy," says Fahey. "Even tabletop ptychographic imaging and EUV acoustic nanometrology will become practical realities for any laboratory." Fahey was the VP of marketing of Xradia (Pleasanton, CA) and VP of marketing, and then CEO of Carl Zeiss X-ray Microscopy following the acquisition of Xradia by Zeiss. He became the senior VP, global marketing and market segments and member of the management board for Carl Zeiss Microscopy, and the digital marketing officer for Carl Zeiss Corporation. Prior to joining Xradia, he was president and CEO of Metrosol. He was also the VP and general manager of the Fab Market Division of FEI Company. Fahey holds a Ph.D. and an M.S. in Materials Science and Engineering from Stanford University and a B.S. in Physics from the Massachusetts Institute of Technology. Fahey assumes the reins of KMLabs immediately, while cofounder Henry Kapteyn will assume the role of EVP, CTO, and board cochair along with Merc Mercure. Cofounder and professor Margaret Murnane will continue on the board of KMLabs, as well as supporting the organization with technology development. Dr. Sterling Backus continues in his role as chief scientist. Source: https://kmlabs.com/kmlabs-receives-new-funding-appoints-fahey-as-ceo/